Back to Trades
Total Value
$154.4K
Filing Date
Mar 3, 2026
1 transactions
Trade Summary
On Feb 28, 2026, Crum Brian T, SVP, General Counsel & Secr., reported $154.4K of LEXICON PHARMACEUTICALS, INC. (LXRX) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $1.47. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- LEXICON PHARMACEUTICALS, INC.
- Ticker Symbol
- LXRX
- CIK
- 0001062822
Insider Information
- Name
- Crum Brian T
- Role
- SVP, General Counsel & Secr.
- Location
- THE WOODLANDS, TX
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 28, 2026
- Accession Number
- 0001062822-26-000036
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 | Common Stock | 33,457 | — | Exercise | — |
| Feb 28, 2026 | Common Stock | 69,386 | — | Exercise | — |
| Feb 28, 2026 | Common Stock | 170,163 | — | Exercise | — |
| Feb 28, 2026 | Common Stock | 105,019 | $1.47 | Tax Withholding | $154.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX derivative | 69,386 | — | Exercise | — |
| Feb 28, 2026 | LXRX derivative | 33,457 | — | Exercise | — |
| Feb 28, 2026 | LXRX derivative | 170,163 | — | Exercise | — |
Want live alerts when Crum Brian T trades again?
Download Insider Trades to track LXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each restricted stock unit represents a contingent right to receive one share of common stock.
- (F2)Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- (F3)Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.